Detection of driver mutations in plasma cell-free nucleic acids in differentiated thyroid neoplasm.

Plasma might be a viable noninvasive alternative source for detection of driver mutations (8-gene panel) in subjects with differentiated thyroid tumors and may have significant clinical utility.